{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:00:06Z","timestamp":1794002406040,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cca.2023.117483","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T11:46:47Z","timestamp":1688644007000},"page":"117483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Newborn screening of maple syrup urine disease and the effect of early diagnosis"],"prefix":"10.1016","volume":"548","author":[{"given":"Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-5119","authenticated-orcid":false,"given":"Lianshu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117483_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207490","article-title":"Brain branched-chain amino acids in maple syrup urine disease: Implications for neurological disorders","volume":"21","author":"Xu","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.cca.2023.117483_b0010","series-title":"Maple syrup urine disease","author":"Hassan","year":"2022"},{"key":"10.1016\/j.cca.2023.117483_b0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1542\/peds.61.2.262","article-title":"Newborn screening for maple syrup urine disease (branched-chain ketoaciduria)","volume":"61","author":"Naylor","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.cca.2023.117483_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040093","article-title":"The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism","volume":"6","author":"Bessey","year":"2020","journal-title":"Int J Neonatal Screen."},{"key":"10.1016\/j.cca.2023.117483_b0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nwh.2017.04.009","article-title":"Implications of maple syrup urine disease in newborns","volume":"21","author":"Harris-Haman","year":"2017","journal-title":"Nurs Womens Health."},{"key":"10.1016\/j.cca.2023.117483_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12687-016-0281-5","article-title":"Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country","volume":"8","author":"De Castro-Hamoy","year":"2017","journal-title":"J Community Genet."},{"key":"10.1016\/j.cca.2023.117483_b0035","first-page":"68","article-title":"Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization","volume":"54","author":"Stroek","year":"2020","journal-title":"JIMD Rep."},{"key":"10.1016\/j.cca.2023.117483_b0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15537\/smj.2020.7.25147","article-title":"Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study","volume":"41","author":"Mohamed","year":"2020","journal-title":"Saudi Med J."},{"key":"10.1016\/j.cca.2023.117483_b0045","first-page":"106","article-title":"Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data","volume":"15","author":"Chapman","year":"2018","journal-title":"Mol Genet Metab Rep."},{"key":"10.1016\/j.cca.2023.117483_b0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ymgme.2010.04.007","article-title":"Incidence of maple syrup urine disease in Portugal","volume":"100","author":"Quental","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2023.117483_b0055","first-page":"8","article-title":"Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany","volume":"47","author":"Simon","year":"2005","journal-title":"Turk J Pediatr."},{"key":"10.1016\/j.cca.2023.117483_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/gtmb.2009.0107","article-title":"DNA carrier testing and newborn screening for maple syrup urine disease in Old Order Mennonite communities","volume":"14","author":"Carleton","year":"2010","journal-title":"Genet Test Mol Biomarkers."},{"key":"10.1016\/j.cca.2023.117483_b0065","doi-asserted-by":"crossref","unstructured":"D. O'Reilly, E. Crushell, J. Hughes, S. Ryan, Y. Rogers, I. Borovickova, P, et al. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland, J Inherit Metab Dis. 44 (2021) 639-655.","DOI":"10.1002\/jimd.12337"},{"key":"10.1016\/j.cca.2023.117483_b0070","first-page":"103","article-title":"Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment","volume":"3","author":"Myers","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.cca.2023.117483_b0075","series-title":"Genereviews","article-title":"Maple syrup urine disease","author":"Strauss","year":"1993"},{"key":"10.1016\/j.cca.2023.117483_b0080","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cca.2010.12.021","article-title":"Proficiency testing outcomes of 3-hydroxyisovalerylcarnitine measurements by tandem mass spectrometry in newborn screening","volume":"412","author":"Lim","year":"2011","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2023.117483_b0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcla.21745","article-title":"Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry","volume":"29","author":"Han","year":"2015","journal-title":"J Clin Lab Anal."},{"key":"10.1016\/j.cca.2023.117483_b0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cca.2018.02.035","article-title":"Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population","volume":"481","author":"Wang","year":"2018","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2023.117483_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Committee, standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.cca.2023.117483_b0100","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1515\/jpem-2020-0746","article-title":"Neonatal maple syrup urine disease in China: Two novel mutations in the BCKDHB gene and literature review","volume":"34","author":"Jiang","year":"2021","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.1016\/j.cca.2023.117483_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet Med."},{"key":"10.1016\/j.cca.2023.117483_b0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejpn.2015.07.009","article-title":"Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis","volume":"19","author":"Couce","year":"2015","journal-title":"Eur J Paediatr Neurol."},{"key":"10.1016\/j.cca.2023.117483_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1550059411429521","article-title":"The electroencephalogram in neonatal maple syrup urine disease: A case report","volume":"43","author":"Agadi","year":"2012","journal-title":"Clin EEG Neurosci."},{"key":"10.1016\/j.cca.2023.117483_b0120","doi-asserted-by":"crossref","unstructured":"F. A. Hassan, F. El-Mougy, S. A. Sharaf, I. Mandour, M. F. Morgan, L. A. Selim, S. et al. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study, J Med Screen. 23 (2016) 124-129.","DOI":"10.1177\/0969141315618229"},{"key":"10.1016\/j.cca.2023.117483_b0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ymgme.2009.11.010","article-title":"Maple syrup urine disease: Further evidence that newborn screening may fail to identify variant forms","volume":"100","author":"Puckett","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2023.117483_b0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/clinchem\/41.1.62","article-title":"Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry","volume":"41","author":"Chace","year":"1995","journal-title":"Clin Chem."},{"key":"10.1016\/j.cca.2023.117483_b0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1005668431926","article-title":"Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises","volume":"23","author":"Wajner","year":"2000","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.cca.2023.117483_b0140","doi-asserted-by":"crossref","unstructured":"C. B. Newgard, J. An, J. R. Bain, M. J. Muehlbauer, R. D. Stevens, L. F. Lien, A. M. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab. 9 (2009) 311-326.","DOI":"10.1016\/j.cmet.2009.02.002"},{"key":"10.1016\/j.cca.2023.117483_b0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1373\/clinchem.2007.098434","article-title":"Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)","volume":"54","author":"Oglesbee","year":"2008","journal-title":"Clin Chem."},{"key":"10.1016\/j.cca.2023.117483_b0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jmsacl.2022.04.003","article-title":"A rapid LC-MS\/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease","volume":"24","author":"Piri-Moghadam","year":"2022","journal-title":"J Mass Spectrom Adv Clin Lab."},{"key":"10.1016\/j.cca.2023.117483_b0155","doi-asserted-by":"crossref","first-page":"103901","DOI":"10.1016\/j.ejmg.2020.103901","article-title":"Clues and challenges in the diagnosis of intermittent maple syrup urine disease","volume":"63","author":"Pode-Shakked","year":"2020","journal-title":"Eur J Med Genet."},{"key":"10.1016\/j.cca.2023.117483_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpeds.2021.06.028","article-title":"Metabolic control and \u201cideal\u201d outcomes in liver transplantation for maple syrup urine disease","volume":"237","author":"Ewing","year":"2021","journal-title":"J Pediatr."},{"key":"10.1016\/j.cca.2023.117483_b0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-3046.2010.01411.x","article-title":"Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: A case series","volume":"15","author":"Shellmer","year":"2011","journal-title":"Pediatr Transplant."},{"key":"10.1016\/j.cca.2023.117483_b0170","first-page":"22","article-title":"Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population","volume":"17","author":"Ali","year":"2018","journal-title":"Mol Genet Metab Rep."},{"key":"10.1016\/j.cca.2023.117483_b0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: Towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum Genet."},{"key":"10.1016\/j.cca.2023.117483_b0180","first-page":"97","article-title":"Molecular genetics of maple syrup urine disease in the Turkish population","volume":"51","author":"Gorzelany","year":"2009","journal-title":"Turk J Pediatr."},{"key":"10.1016\/j.cca.2023.117483_b0185","doi-asserted-by":"crossref","unstructured":"O. A. Khalifa, F. Imtiaz, K. Ramzan, O. Zaki, R. Gamal, L. Elbaik, S. R. et al. Genotype-phenotype correlation of 33 patients with maple syrup urine disease, Am J Med Genet A. 182 (2020) 2486-2500.","DOI":"10.1002\/ajmg.a.61806"},{"key":"10.1016\/j.cca.2023.117483_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijns7020025","article-title":"Challenges in diagnosing intermediate maple syrup urine disease by newborn screening and functional validation of genomic results imperative for reproductive family planning","volume":"7","author":"Sajeev","year":"2021","journal-title":"Int J Neonatal Screen."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:11:06Z","timestamp":1757862666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123002851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":38,"alternative-id":["S0009898123002851"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117483","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn screening of maple syrup urine disease and the effect of early diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117483"}}